Related Experiment Videos

The MDM2 RING finger is required for cell cycle-dependent regulation of its protein expression

Ling Gu1, Haoqiang Ying, Hongwu Zheng

  • 1Department of Biochemistry, Boston University School of Medicine, 715 Albany Street, K423, MA 02118, USA.

FEBS Letters
|June 5, 2003
PubMed

Insights

MDM2 oncoprotein regulates cell division and is overexpressed in cancers. This study reveals MDM2 protein levels are controlled by the cell cycle, stabilizing during S phase to promote cell growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Cycle Regulation

Background:

  • The MDM2 oncoprotein is frequently overexpressed in human tumors.
  • MDM2 acts as an E3 ligase for p53 and itself, and interacts with RB and E2F1 to drive cell cycle progression.
  • Understanding MDM2's role in cell cycle regulation is crucial for cancer therapy.

Purpose of the Study:

  • To investigate the cell cycle regulation of MDM2 protein expression.
  • To determine the molecular mechanisms underlying MDM2's cell cycle control.
  • To elucidate the role of MDM2 in promoting cell cycle S-phase entry.

Main Methods:

  • Analysis of MDM2 protein expression levels throughout the cell cycle.
  • Investigation of MDM2 ubiquitination and its dependence on the RING finger domain and Lys446.
  • Assessment of the impact of MDM2 overexpression on E2F activity and cell cycle distribution.

Main Results:

  • MDM2 protein expression is regulated by the cell cycle, requiring its RING finger domain and Lys446.
  • MDM2 protein is notably stabilized during the S phase of the cell cycle.
  • Overexpression of MDM2 leads to increased E2F activity and accumulation of cells in S phase.

Conclusions:

  • MDM2 ubiquitination is a cell cycle-regulated process.
  • MDM2 plays a significant role in the progression of the cell cycle, particularly during S phase.
  • Targeting MDM2's cell cycle regulatory functions may offer novel therapeutic strategies for cancer.

Related Concept Videos